Hydroxychloroquine/azithromycin treatment, QT interval and ventricular arrhythmias in hospitalised patients with COVID-19.

İbrahim Halil ÖzdemirBülent ÖzlekMehmet Burak ÖzenRamazan GündüzNurullah ÇetinAli Rıza Bilge

Published in: International journal of clinical practice (2020)

The present study revealed that although HCQ + AZM treatment was independently associated with QTc prolongation, none of patients experienced malignant ventricular arrhythmia or death during treatment. Further prospective studies are needed to determine the exact implications of these drugs on arrhythmias in patients with COVID-19.

Keyphrases

heart failure
end stage renal disease
ejection fraction
left ventricular
chronic kidney disease
prognostic factors
combination therapy
patient reported outcomes
case control